Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.98 USD | -0.67% | +1.49% | -45.74% |
06:25pm | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
23/04 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.74% | 2.82B | |
+0.54% | 42.86B | |
+12.32% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+6.21% | 25.15B | |
-23.45% | 18.63B | |
+28.16% | 12.37B | |
-3.16% | 11.92B | |
+7.38% | 11.21B |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- Sector Update: Health Care Stocks Adding to Midday Gains Near Close